Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432986 · ClinicalTrials.gov registry record
Assessment of CSF Shunt Flow With Thermal Measurements B
A clinical trial of Hydrocephalus, sponsored by Rhaeos.
- Completed
- Registry status
- 141
- Enrollment target
- 10
- Study locations
NCT05432986: Completed study of Hydrocephalus, sponsored by Rhaeos.
NCT05432986 is a study of Hydrocephalus that has completed, run by Rhaeos. The registered enrollment target is 141 participants, above the 125-participant average among 17 other Hydrocephalus trials with a reported enrollment target (13% higher). The trial reports 10 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05432986, a study of Hydrocephalus, has completed, sponsored by Rhaeos.
- COMPLETED
- Registry status
- 141 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.
Primary Outcome
Study device sensitivity is calculated as TP / (TP + FN), where TP = true positive and FN = false negative.
Conditions Studied
Interventions
- DEVICE Thermal Anisotropy Measurement Device
Study Locations (10)
Illinois
- Lurie Children's Hospital - Chicago
- Northwestern Memorial Hospital - Chicago
- University of Illinois Chicago - Chicago
California
- UCSF Benioff Children's Hospital - Oakland
- UCSF Benioff Children's Hospital - San Francisco
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
- Dayton Children's Hospital - Dayton
Missouri
- Washington University in St. Louis - St Louis
New York
- Lenox Hill Hospital - New York
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2022-07-07 |
| Est. Completion | 2023-11-10 |
What the finished NCT05432986 record still lists
NCT05432986 is an observational study that tracks outcomes without assigning an intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, above the 125-participant average among 17 other Hydrocephalus trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Hydrocephalus appearing as the primary indexed condition, and to 1 intervention - of which Thermal Anisotropy Measurement Device is the first listed.
NCT05432986 lists 10 locations in 6 states (Illinois, California, Ohio).
Frequently Asked Questions
What is clinical trial NCT05432986 about?
NCT05432986 is a clinical study titled "Assessment of CSF Shunt Flow With Thermal Measurements B". This study evaluates the performance of a non-invasive thermal measurement device for assessing CSF shunt flow. Patients with an existing implanted shunt and symptoms of shunt malfunction will be evaluated with the study device.
What is the current status of trial NCT05432986?
This trial is currently completed. The enrollment target is 141 participants. The study started on 2022-07-07. Estimated completion is 2023-11-10.
What conditions does trial NCT05432986 study?
This clinical trial studies the following conditions: Hydrocephalus.
What interventions are being tested in trial NCT05432986?
The interventions under investigation include: Thermal Anisotropy Measurement Device (DEVICE).
Who is sponsoring clinical trial NCT05432986?
This trial is sponsored by Rhaeos, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05432986 being conducted?
This trial has 10 study locations across California, Illinois, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hydrocephalus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05432986's enrollment target sits among peer trials
141 5th of 17 higher than 13 of 17 other Hydrocephalus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hydrocephalus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NIRS Monitoring in Premature Infants
RECRUITING
-
Assessment of CSF Shunt Flow and Headaches With a Thermal Measurement Device
RECRUITING · NA
-
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
RECRUITING · NA
-
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
RECRUITING · NA
-
CoMind Early Feasibility Study
RECRUITING
-
Flow Detection in Open and Closed Shunt Valve Periods
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI